Hoyoung M Maeng, M.D.

Trials

Studies that name Hoyoung M Maeng, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:03 UTC. Open this list on ClinicalTrials.gov

• Ph1/Ph2
  NCT06253494 · Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer

  National Cancer Institute (NCI) · recruiting · Endometrial Cancer, Cancer of Endometrium, Carcinoma of Endometrium · principal investigator
• Ph1/Ph2
  NCT04708470 · A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers

  National Cancer Institute (NCI) · completed · Oropharyngeal Cancer, Neck Cancer, Human Papillomavirus · principal investigator
• Ph2
  NCT02362464 · Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139

  National Cancer Institute (NCI) · completed · Prostatic Neoplasms, Neoplasms of Prostate, Prostate Cancer · principal investigator
• Ph2
  NCT02362451 · Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Men With Stage D0 Prostate Cancer

  National Cancer Institute (NCI) · terminated · Prostatic Neoplasms, Prostate Cancer · principal investigator
• Ph1
  NCT01730118 · Ad/HER2/Neu Dendritic Cell Cancer Vaccine Testing

  National Cancer Institute (NCI) · completed · Breast Neoplasms, Breast Cancer, Adenocarcinomas · principal investigator
• Ph1
  NCT00972309 · A Pilot Study of Vaccination With Epitope-Enhanced TARP Peptide and TARP Peptide-Pulsed Dendritic Cells in the Treatment of Stage D0 Prostate Cancer

  National Cancer Institute (NCI) · completed · Prostate Specific Antigens, Prostate Neoplasms · principal investigator
• Ph1
  NCT00798265 · A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents, and Young Adults

  National Cancer Institute (NCI) · terminated · Human Immunodeficiency Virus, Human Papillomavirus- 6, 11, 16, 18, Adolescent · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 13:03 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.